Welcome to LookChem.com Sign In|Join Free

CAS

  • or

157021-70-0

Post Buying Request

157021-70-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

157021-70-0 Usage

Description

2,6-Dichloro-4-(trifluoromethyl)benzamide is an organic chemical compound that belongs to the class of organohalogen compounds. Its molecule is characterized by a benzamide moiety, which is essentially a benzene ring attached to an amide group. In its structure, two chlorine atoms are attached to the benzene ring at positions 2 and 6, respectively, while a trifluoromethyl group is attached at the 4th position. 2,6-DICHLORO-4-(TRIFLUOROMETHYL)BENZAMIDE is typically found in solid form and is relatively stable under normal conditions. Its specific properties, including the presence of fluorine and chlorine atoms, could be advantageous in various industrial applications.

Uses

Used in Pharmaceutical Industry:
2,6-Dichloro-4-(trifluoromethyl)benzamide is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its unique structure, with fluorine and chlorine atoms, can contribute to the development of new drugs with improved properties, such as increased stability, bioavailability, or targeted activity.
Used in Agrochemical Industry:
2,6-Dichloro-4-(trifluoromethyl)benzamide is used as a starting material for the production of agrochemicals, such as pesticides and herbicides. The presence of halogen atoms in its structure can enhance the effectiveness of these compounds in controlling pests and weeds, while also potentially reducing their environmental impact.
Used in Material Science:
2,6-Dichloro-4-(trifluoromethyl)benzamide is used as a building block in the synthesis of advanced materials, such as polymers and coatings, with specific properties tailored for various applications. The incorporation of fluorine and chlorine atoms can improve the durability, chemical resistance, or thermal stability of these materials.
Used in Chemical Research:
2,6-Dichloro-4-(trifluoromethyl)benzamide serves as a valuable research compound for studying the effects of halogen substitution on the properties and reactivity of organic molecules. This knowledge can be applied to the design of new compounds with desired characteristics for various applications in academia and industry.

Check Digit Verification of cas no

The CAS Registry Mumber 157021-70-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,7,0,2 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 157021-70:
(8*1)+(7*5)+(6*7)+(5*0)+(4*2)+(3*1)+(2*7)+(1*0)=110
110 % 10 = 0
So 157021-70-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H4Cl2F3NO/c9-4-1-3(8(11,12)13)2-5(10)6(4)7(14)15/h1-2H,(H2,14,15)

157021-70-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2,6-DICHLORO-4-(TRIFLUOROMETHYL)BENZAMIDE

1.2 Other means of identification

Product number -
Other names 2,6-Dichloro-4-trifluoromethylbenzamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:157021-70-0 SDS

157021-70-0Upstream product

157021-70-0Downstream Products

157021-70-0Relevant articles and documents

2-OXOQUINAZOLINE DERIVATIVES AS METHIONINE ADENOSYLTRANSFERASE 2A INHIBITORS

-

Paragraph 00303; 00307, (2020/07/08)

Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): (IA) that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 157021-70-0